I recall seeing all of that except the "normal production of antibodies" part (which I may have missed)... LLMab restores CD4 - CD8 balance, I don't recall ever seeing that host antibody production gets impaired.

Every other treatment I'm familiar with suppresses the immune system, which usually results in issues with secondary infections and malignancies (with long term use).